Dr. Richard Moulange

speaker
1,784 appearances 1 recordings 1 series first heard Mar 2026 last heard 31 Mar

Dr. Richard Moulange’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Mar OctJan 26AprJulnow

Recordings per month over the last 12 months — 1 in all, peaking in Mar 2026 with 1.

Appearances

newest first · ▶ plays the moment
Got anything more concrete?
Anything more robust?
Fair enough.
I think there are some reasons to be less pessimistic than that.
So the first is, I think you subtly substituted for two different capabilities.
You said, suppose we have great vaccine design capabilities.
We'll also probably have really good sequence-to-function design.
The first is a much more narrow subdomain than the second, which is a deeply enabling cross biology generalized capability.
You know, we can have alpha fault structure prediction without having, I mean, that's actually quite general, I suppose, but we don't have yet to have sequence to function.
And so this I think links back to the idea of differential technological development.
We should be choosing to develop vaccine design technologies as far as possible without always relying on broader dual-use biodesign technologies if we don't have to.
Sometimes we will, but we should squeeze all the defensive juice out of a defense-dominant subdomain first.
The second thing you said was then maybe they could optimize against you.
I think this is an open question.
If we have truly multi-strain vaccines or universal vaccines within a class, it should be that, think about that embedding space of biology again.
If there's this circle here, that's all the influenzas, at some point you might have a vaccine that just works against all of them.
That doesn't preclude very advanced actors from starting to explore
You know, a whole new family of, you know, there are 26 human-infected viral families that we know of, you know, could you go into the 30s or something?
Sure.
But that still cuts down so much of the risk.
Showing 1221–1240 of 1,784 · page 62 of 90 ← Previous Next →